<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://bioitalliance.org/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>strandls</title><link>http://bioitalliance.org/blogs/strandls/default.aspx</link><description /><dc:language>en-US</dc:language><generator>CommunityServer 2.0 (Debug Build: 60217.2664)</generator><item><title>Strand Launches Sarchitect for in-silico Lead Optimization </title><link>http://bioitalliance.org/blogs/strandls/archive/2007/04/02/153.aspx</link><pubDate>Mon, 02 Apr 2007 14:18:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:153</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/153.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=153</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/153.aspx</wfw:comment><description>&lt;P class=MsoNormal&gt;&lt;SPAN&gt;&lt;FONT face=Arial&gt;Strand Life Sciences announces the launch of its SAR modelling and deployment platform – Sarchitect.&lt;SPAN&gt;&amp;nbsp; &lt;/SPAN&gt;Sarchitect addresses the challenge of taking the model building prowess of computational chemists through to decision support in medicinal chemistry. Gilead Sciences, Inc. has signed on as the first customer of Sarchitect.&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=153" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/Sarchitect_launch_press_release.pdf" length="68754" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1108.aspx">News</category></item><item><title>Strand named Technology Pioneer 2007 by World Economic Forum</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/12/06/84.aspx</link><pubDate>Wed, 06 Dec 2006 16:47:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:84</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/84.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=84</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/84.aspx</wfw:comment><description>Press Release announcing Strand's selection as Technology Pioneer 2007 by the World Economic Forum on December 4, 2006....(&lt;a href="http://bioitalliance.org/blogs/strandls/archive/2006/12/06/84.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=84" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/press_release_for_Tech_Pioneer_2007.pdf" length="160058" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1108.aspx">News</category></item><item><title>Strand Joins Microsoft Promoted BioIT Alliance</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/18/70.aspx</link><pubDate>Wed, 18 Oct 2006 04:52:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:70</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/70.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=70</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/70.aspx</wfw:comment><description>
Strand Life Sciences, a Bangalore-based life sciences informatics company announced today
that it has joined the BioIT Alliance formed by Microsoft....(&lt;a href="http://bioitalliance.org/blogs/strandls/archive/2006/10/18/70.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=70" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/press_bioitalliance.pdf" length="26986" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1108.aspx">News</category></item><item><title>Strand joins Microsoft's BioIT Alliance</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/17/56.aspx</link><pubDate>Tue, 17 Oct 2006 04:09:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:56</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/56.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=56</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/56.aspx</wfw:comment><description>&lt;P&gt;Bangalore, India | October 17, 2006&lt;/P&gt;
&lt;P&gt;Strand Life Sciences becomes a member of the BioIT Alliance.&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=56" width="1" height="1"&gt;</description><enclosure url="http://bioitalliance.org/blogs/files/24/56/press_bioitalliance.pdf" length="26986" type="application/pdf" /></item><item><title>Strand-Stratagene White Papers Series - Grammatica: The PathwayArchitect NLP Engine</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/33.aspx</link><pubDate>Tue, 03 Oct 2006 10:27:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:33</guid><dc:creator>strandls</dc:creator><slash:comments>1</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/33.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=33</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/33.aspx</wfw:comment><description>&lt;FONT face=Arial&gt;&lt;FONT face=Courier&gt;
&lt;P align=left&gt;&lt;FONT face=Arial size=2&gt;An innovative solution from Strand-Stratagene to design fully automated natural language processing systems that can extract biological interactions from literature&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=2&gt;.&lt;/FONT&gt;&lt;/P&gt;&lt;/FONT&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=33" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/nlp.pdf" length="188568" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1111.aspx">White Papers</category></item><item><title>Case Study - Classification in avadis</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/32.aspx</link><pubDate>Tue, 03 Oct 2006 10:24:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:32</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/32.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=32</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/32.aspx</wfw:comment><description>&lt;TABLE cellSpacing=0 cellPadding=5&gt;

&lt;TR&gt;
&lt;TD class=resrs-td3-bgclr&gt;&lt;/TD&gt;
&lt;TD&gt;
&lt;P&gt;&lt;FONT face=Arial size=2&gt;Analysis of classification and prediction algorithms in avadis 2.0 on the Lymphoma dataset.&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TABLE&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=32" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/avadis_classification.pdf" length="1311415" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item><item><title>Case Study - Clustering in avadis</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/31.aspx</link><pubDate>Tue, 03 Oct 2006 10:21:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:31</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/31.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=31</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/31.aspx</wfw:comment><description>&lt;P&gt;&lt;FONT face=Arial size=2&gt;Comparative analysis of clustering results on the Diauxic dataset.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=31" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/avadis_clustering.pdf" length="901917" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item><item><title>Case Study - Enterprise scale data visualization of pre-clinical data</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/30.aspx</link><pubDate>Tue, 03 Oct 2006 10:19:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:30</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/30.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=30</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/30.aspx</wfw:comment><description>&lt;P&gt;&lt;FONT face=Arial size=2&gt;This case study describes an instance of enterprise-scale data access and visualization using Strand's proprietary technology platform - avadis.&amp;nbsp;It was&amp;nbsp;deployed in a prominent antibody research company in USA.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=30" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/PreClinical_data_casestudy.pdf" length="248887" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item><item><title>Case Study - Modeling with Neural Networks to predict Mechanism of Action</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/29.aspx</link><pubDate>Tue, 03 Oct 2006 10:16:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:29</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/29.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=29</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/29.aspx</wfw:comment><description>&lt;P&gt;&lt;FONT face=Arial size=2&gt;This study is to showcase a way to predict a drug's mechanism of action from its pattern of activity against a panel of 60 malignant cell lines in the National Cancer Institute's drug screening program.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=29" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/MechanismofAction_casestudy.pdf" length="522540" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item><item><title>Case Study - Cluster Analysis of Two-Color Data: Human *** Tumor Diversity</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/28.aspx</link><pubDate>Tue, 03 Oct 2006 10:12:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:28</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/28.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=28</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/28.aspx</wfw:comment><description>&lt;P&gt;&lt;FONT face=Arial size=2&gt;65 surgical specimens of Human&amp;nbsp;*** Tumors from 42 different individuals were studies using c-DNA microarrays representing about 9000 human genes.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=28" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/2dye_data_casestudy.pdf" length="695383" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item><item><title>Case Study - Affymetrix Time Course Data: Myeloid Cell Differentiation</title><link>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/27.aspx</link><pubDate>Tue, 03 Oct 2006 08:59:00 GMT</pubDate><guid isPermaLink="false">9206313b-73a6-4b55-a104-a0254c229ae1:27</guid><dc:creator>strandls</dc:creator><slash:comments>0</slash:comments><comments>http://bioitalliance.org/blogs/strandls/comments/27.aspx</comments><wfw:commentRss>http://bioitalliance.org/blogs/strandls/commentrss.aspx?PostID=27</wfw:commentRss><wfw:comment>http://bioitalliance.org/blogs/rsscomments/27.aspx</wfw:comment><description>&lt;P&gt;&lt;FONT face=Arial size=2&gt;The goal of this study is to identify the cascade of genes expression changes, which occur in the MPRO mouse cell line.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=27" width="1" height="1"&gt;</description><enclosure url="http://www.strandls.com/files/Affymetrix_Time_Course_Data_Analysis.pdf" length="499835" type="application/pdf" /><category domain="http://bioitalliance.org/blogs/strandls/archive/category/1107.aspx">Case Studies</category></item></channel></rss>